ALTSTATION.IO

Ecolab Inc. (ECL) Stock Analysis

By Nova Skye | AltStation.io | Updated October 24, 2026

Price

$289.11

Change

-1.09%

Market Cap

$81.05B

Avg Volume

1.4M

Company Overview

Ecolab Inc. is a specialty chemicals company founded in 1923 and headquartered in Saint Paul, Minnesota. The business sells water treatment systems, industrial sanitizers, and pest control services across four primary segments: Global Water, Global Institutional and Specialty, Global Pest Elimination, and Global Life Sciences. Its customer base spans restaurants, hotels, hospitals, pharmaceutical manufacturers, and heavy industrial operations like refineries and power plants. Ecolab delivers these products directly through dedicated field sales reps and corporate account teams who install proprietary dispensing hardware directly on customer sites.

Ecolab is the clear market leader in commercial hygiene and industrial process water treatment. Its primary competitive moat comes from high customer switching costs. Once a hotel chain, hospital, or manufacturing plant integrates Ecolab’s automated dispensers and proprietary chemical formulations into daily operations, replacing them creates operational friction and downtime. The company faces ongoing exposure to raw material price swings and competition from regional chemical formulators, but its massive global scale provides pricing power that smaller rivals cannot match.

Ecolab is executing a disciplined margin-expansion playbook, generating $15.7 billion in revenue in 2024, a 3% increase over 2023. Operating income surged 41% to $2.8 billion over the same period as value pricing took hold and product delivery costs normalized. Management has also streamlined operations by folding healthcare into the Institutional segment, divesting non-core surgical assets, and expanding higher-margin lines like Pest Elimination and Life Sciences. The business is a steady cash-flow generator that successfully charges a premium for essential, non-negotiable operational hygiene.

Key Financials

Market Cap

$81.05B

Revenue

$16.84B

EBITDA

$4.14B

Gross Margin

44.2%

Profit Margin

12.6%

Revenue Growth

9.7%

Total Cash

$5.14B

Total Debt

$13.92B

Free Cash Flow

$1.47B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

38.24

Forward P/E

30.81

Beta

0.88

52-Week High

$309.27

52-Week Low

$243.15

EPS

$7.56

50-Day Avg

$280.17

200-Day Avg

$275.28

Price/Book

8.06

Technical Analysis

ECL trades at $289.11, 72% of the way from its 52-week low of $241.85 to its high of $306.79. The stock is 5.95% below that high and 19.30% above the low, so the broader trend remains positive. Price sits 2.00% above the 20-day moving average of $282.88, while 20-day momentum is positive at 3.23%. Five-day momentum is weaker at -0.12%, showing that the recent advance has stalled. Near-term support is $269.46, while resistance sits at $292.30.

Recent News and Developments

Ecolab invests in wastewater-filtration company ZwitterCo

Ecolab made an undisclosed strategic investment in ZwitterCo on October 22. The companies plan to combine ZwitterCo’s membrane systems with Ecolab’s water-treatment programs, chemistry, digital monitoring and on-site services for food and beverage manufacturers. Source: PR Newswire

Eagan approves Ecolab’s $500 million innovation center

The Eagan City Council approved Ecolab’s plan to invest $500 million in its Minnesota research campus. Construction is expected to run from 2027 through 2030 and add 105,000 square feet, bringing the campus to roughly 725,000 square feet. Source: Twin Cities Business

Morgan Stanley and Bank of America stick with Buy ratings

Morgan Stanley reiterated its Buy rating on Ecolab on October 20 with a $330 price target. Bank of America also reiterated a Buy rating that day, so there was no fresh upgrade or downgrade from either firm. Source: TipRanks

Market Sentiment and Analyst Recommendations

Bull Case

Revenue is growing 9.7% on a $16.84 billion base, which gives Ecolab a credible fundamental growth story. The analyst consensus is buy across 21 analysts, with a $325.05 target and a range of $295.00 to $360.00. Even the low target of $295.00 is above the current $289.11 price. Ecolab’s October 22 investment in ZwitterCo adds wastewater-filtration technology to its water-treatment programs, chemistry, digital monitoring and on-site services for food and beverage manufacturers. The approved $500 million Minnesota innovation center is another clear commitment to future research capacity, with the campus expected to reach roughly 725,000 square feet. The stock is also above its $282.88 moving average and has gained 3.23% over the last 20 trading days. The bull case is straightforward: solid revenue growth, expanding water technology capabilities and analyst targets above the current price.

Bear Case

The biggest problem is valuation: ECL trades at 38.24 times earnings. That multiple leaves little room for weak growth or disappointing execution. Total debt of $13.92 billion is well above total cash of $5.14 billion, limiting the balance-sheet cushion. The planned $500 million innovation center is a long-term commitment, with construction expected to run from 2027 through 2030. The ZwitterCo investment could strengthen Ecolab’s offering, but the investment amount was not disclosed, so investors cannot assess its financial impact from the available data. The preliminary pension-lawsuit settlement also carries uncertainty because its terms were not reported. With the stock only 5.95% below its 52-week high, a valuation reset could be painful if revenue growth falls below the current 9.7%.

What to Watch

The first technical test is $292.30, the 30-day high and near-term resistance level. A move lower should put attention on the $282.88 moving average, followed by support at $269.46. Investors should track whether revenue growth holds near 9.7%, because a 38.24 P/E demands continued execution. Watch for financial details on the October 22 ZwitterCo investment and evidence that the combined filtration and water-treatment offering gains traction with food and beverage manufacturers. The terms of the pension-lawsuit settlement also matter because no financial amount has been reported. Morgan Stanley’s October 20 target of $330 and the broader analyst target of $325.05 provide clear benchmarks against the current $289.11 price. A break above $292.30 would strengthen the near-term chart, while a drop below $269.46 would weaken the thesis.

Analyst Consensus

BUY

Based on 21 analyst opinions

Low Target

$295.00

Mean Target

$325.05

High Target

$360.00

Earnings and Financial Data

Sector

Basic Materials

Industry

Specialty Chemicals

Employees

48,000

Earnings & Dividends

Next Earnings

Oct 27, 2026

EPS (Trailing)

$7.56

Dividend Yield

100.0%

Payout Ratio

38.1%

Frequently Asked Questions

Is ECL a good stock to buy?

The recommendation is buy based on 21 analysts, and revenue is growing 9.7%. The clear takeaway is that Wall Street is positive, but the 38.24 P/E makes the entry price important.

What is ECL’s price target?

The analyst target is $325.05, with estimates ranging from $295.00 to $360.00. The takeaway is that every listed target is above the current $289.11 price.

Is ECL stock overvalued?

ECL trades at a P/E of 38.24, which is a demanding valuation relative to its 9.7% revenue growth. The takeaway is that investors are already paying a high price for continued growth.

What are ECL’s support and resistance levels?

Near-term support is $269.46, and near-term resistance is $292.30. The takeaway is that $292.30 is the immediate upside test, while $269.46 is the key downside level.

How strong is ECL’s balance sheet?

Ecolab has $5.14 billion in total cash and $13.92 billion in total debt. The takeaway is that debt substantially exceeds cash.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated October 24, 2026.